Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) has received a consensus recommendation of “Hold” from the twenty-three research firms that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target […]
